Top-Rated Dividend StocksTop-Rated DividendNASDAQ:RPRX Royalty Pharma (RPRX) Insider Trading & Ownership $33.63 +0.87 (+2.66%) (As of 05/18/2023 ET) Add Compare Share Share Today's Range$33.22▼$33.9150-Day Range$32.77▼$37.3952-Week Range$32.67▼$44.66Volume2.18 million shsAverage Volume1.82 million shsMarket Capitalization$20.42 billionP/E Ratio61.15Dividend Yield2.38%Price Target$54.00 Insider TradesProfileAnalyst RatingsChartCompetitorsDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaSustainabilityProfileAnalyst RatingsChartCompetitorsDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaSustainability Royalty Pharma (NASDAQ:RPRX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage24.86%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$5.38 MNumber OfInsiders Selling(Last 12 Months)8Amount OfInsider Selling(Last 12 Months)$121.58 M RPRX Insider Buying and Selling by Quarter Get RPRX Insider Trade Alerts Want to know when executives and insiders are buying or selling Royalty Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Royalty Pharma Insider Trades History Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails5/16/2023Pablo G LegorretaCEOBuy160,388$33.57$5,384,225.16160,388 3/29/2023Rory B RiggsDirectorSell9,926$36.95$366,765.701,586,786 3/28/2023George W LloydEVPSell100,000$37.06$3,706,000.00225,000 2/22/2023Marshall UristEVPSell23,333$37.30$870,320.9046,667 12/12/2022Rory B RiggsDirectorSell40,010$41.98$1,679,619.8096,712 12/9/2022Rory B RiggsDirectorSell19,990$42.07$840,979.30136,722 12/5/2022Mario Germano GiulianiDirectorSell84,302$43.15$3,637,631.307,795,072 12/1/2022Mario Germano GiulianiDirectorSell165,000$44.10$7,276,500.0022,225,000 11/21/2022George W LloydEVPSell23,631$43.11$1,018,732.41144,469 11/17/2022Rory B RiggsDirectorSell120,000$42.33$5,079,600.00156,712 11/10/2022George W LloydEVPSell50,000$43.85$2,192,500.00165,000 11/8/2022Terrance P CoyneCFOSell24,500$43.47$1,065,015.00940,000 11/2/2022Terrance P CoyneCFOSell5,500$43.06$236,830.00964,500 9/28/2022James F ReddochEVPSell100,000$41.23$4,123,000.00820,800 9/28/2022Mario Germano GiulianiDirectorSell32,593$41.05$1,337,942.658,077,140 9/21/2022Mario Germano GiulianiDirectorSell125,697$41.25$5,185,001.258,321,113 9/20/20221978 Sicaf Sif S.A. - Gg St GgMajor ShareholderSell267,815$41.02$10,985,771.3021,426,170 9/19/2022Mario Germano GiulianiDirectorSell232,185$41.50$9,635,677.5022,657,815 9/16/2022Mario Germano GiulianiDirectorSell154,986$41.72$6,466,015.9222,890,000 9/14/20221978 Sicaf Sif S.A. GgMajor ShareholderSell190,860$42.48$8,107,732.8022,235,310 9/14/2022Rory B RiggsDirectorSell47,975$42.41$2,034,619.75328,737 9/7/20221978 Sicaf Sif S.A. - Gg St GgMajor ShareholderSell250,000$42.53$10,632,500.0022,674,176 9/7/2022Mario Germano GiulianiDirectorSell261,881$42.66$11,171,843.468,814,759 8/25/20221978 Sicaf Sif S.A. - Gg St GgMajor ShareholderSell1,994$44.00$87,736.0022,924,176 8/25/2022Mario Germano GiulianiDirectorSell500$44.00$22,000.009,076,640 8/9/2022George W LloydEVPSell11,859$43.92$520,847.28210,109 8/9/2022Rory B RiggsDirectorSell45,000$43.73$1,967,850.00376,712 8/1/2022Terrance P CoyneCFOSell30,000$43.19$1,295,700.00970,000 7/27/2022George W LloydEVPSell25,100$43.76$1,098,376.00226,014 7/25/2022George W LloydEVPSell30,671$42.93$1,316,706.03228,886 6/29/2022Rory B RiggsDirectorSell30,000$42.17$1,265,100.00421,712 6/24/2022Marshall UristEVPSell23,333$43.19$1,007,752.2723,334 6/8/2022James F ReddochEVPSell100,000$41.56$4,156,000.00920,800 5/27/2022James F ReddochEVPSell75,000$41.08$3,081,000.001,020,800 5/23/2022George W LloydEVPSell100,000$40.27$4,027,000.00530,000 5/19/2022James F ReddochEVPSell75,000$40.44$3,033,000.001,095,800 5/19/2022Rory B RiggsDirectorSell26,304$40.09$1,054,527.36575,408 (Data available from 1/1/2013 forward) RPRX Insider Trading Activity - Frequently Asked Questions Who is on Royalty Pharma's Insider Roster? The list of insiders at Royalty Pharma includes 1978 Sicaf Sif S.A. - Gg St Gg, 1978 Sicaf Sif S.A. Gg, Adage Capital Partners Gp, L.L, George W Lloyd, Henry A Fernandez, James F Reddoch, Mario Germano Giuliani, Marshall Urist, Pablo G Legorreta, Rory B Riggs, Terrance P Coyne, and William E Ford. Learn more on insiders at RPRX. What percentage of Royalty Pharma stock is owned by insiders? 24.86% of Royalty Pharma stock is owned by insiders. Learn more on RPRX's insider holdings. Which Royalty Pharma insiders have been buying company stock? The following insiders have purchased RPRX shares in the last 24 months: Henry A Fernandez ($1,218,425.00), and Pablo G Legorreta ($5,384,225.16). How much insider buying is happening at Royalty Pharma? Insiders have purchased a total of 192,888 RPRX shares in the last 24 months for a total of $6,602,650.16 bought. Which Royalty Pharma insiders have been selling company stock? The following insiders have sold RPRX shares in the last 24 months: 1978 Sicaf Sif S.A. - Gg St Gg ($21,706,007.30), 1978 Sicaf Sif S.A. Gg ($8,107,732.80), George W Lloyd ($24,700,672.36), James F Reddoch ($14,393,084.00), Mario Germano Giuliani ($44,732,612.08), Marshall Urist ($4,939,324.48), Rory B Riggs ($65,193,335.45), and Terrance P Coyne ($2,597,545.00). How much insider selling is happening at Royalty Pharma? Insiders have sold a total of 4,521,233 Royalty Pharma shares in the last 24 months for a total of $189,363,304.22 sold. More Insider Trading Tools from MarketBeat Related Companies: Invitation Homes Insider Buying ORIX Insider Buying Alexandria Real Estate Equities Insider Buying Extra Space Storage Insider Buying M&T Bank Insider Buying The Hartford Financial Services Group Insider Buying Ventas Insider Buying Brown & Brown Insider Buying Raymond James Insider Buying CBRE Group Insider Buying Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: 3 High-Yield Banks Insiders Are Buying Insiders Drive Volatility For Keurig Dr PepperInsiders Buy Wag! Group, Sell-Side Buys Too Insiders Buy EasyJet, Regularly And Repeatedly 3 Healthcare Stocks Insiders Are Buying This page (NASDAQ:RPRX) was last updated on 5/18/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Royalty Pharma plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.